Attana now offers self sampling for expanded diagnostic testing capabilities with an updated CE IVD-marking
Attana now enables self sampling through an updated CE IVD-marking for capillary blood samples using Capitainer[®]qDBS cards (quantitative dried blood spot), enabling laboratories improved opportunities to perform immune profiling and monitoring of vaccine efficacy in broad patient populations.As presented together with Capitainer in February 2022, the goal of Attana Diagnostics is to offer broader and more patient-centric blood sampling solutions for the Attana AVA[TM] system. Since then, Attana has validated its AVA[TM] SARS-CoV-2 IgG Immunoassay kit for capillary blood samples, both qDBS
Attana has today launched the Attana Cell 250 instrument which features a new and fully integrated autosampler, delivering vastly improved sample handling and instrument operation.Since 2019, Attana has been working closely with ModuVision Technologies BV (Vlissingen, The Netherlands) to integrate their flagship product, the PRIMARIZ robotic autosampler, into the Attana system. The Attana Cell 250 is the first result of this cooperation.
“We are proud to welcome Attana to our ever-growing customer base and with this, enter into new application fields,” comments Jan Willem Mol, CEO of